IP Library Granted Patent US 6,995,835
Granted Patent B2
US 6,995,835 · App. 10/056,205 · Granted Feb 7, 2006

Method and apparatus for measuring analytes in blood bags

Assignee: NIR Diagnostics Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,995,835
App. No.
10/056,205
Granted
Feb 7, 2006
Kind
B2
Abstract

The present invention provides a method for determining a concentration of at least one analyte in a sample contained in a blood bag or in tubing in fluid communication with said blood bag, using an instrument comprising at least one calibration algorithm for the at least one analyte. The method comprises irradiating a sample in the tubing or the blood bag, using a near infrared and adjacent visible radiation source. Then measuring absorbance from the sample for the at least one analyte, and calculating a concentration of the at least one analyte using the absorbance and the at least one calibration algorithm.

Claims (14)

1. A method for determining a concentration of one, or more than one analyte in a sample contained in a blood bag or in a tubing in fluid communication with said blood bag, using an instrument comprising one, or more than one calibration algorithm for said one, or more than one analyte, said method comprising:

a) irradiating said sample in said tubing, or said blood bag, using a radiation source of about 475 nm to about 2,700 nm;

b) measuring an absorbance of said sample; and

c) calculating a concentration of said one, or more than one analyte using said absorbance and said one, or more than one calibration algorithm.

2. The method of claim 1 , wherein said step of calculating (step c)) comprises determining values of first derivatives of two, or more than two portions of a spectrum generated from said step of measuring (step b), and incorporating said first derivatives into said one, or more than one calibration algorithm to provide said concentration.

3. The method of claim 1 wherein said blood bag, or said tubing is translucent and contains writing on its surface and irradiation is transmitted through said writing, said blood bag or said tubing, and said sample contained in said blood bag or said tubing.

4. The method of claim 1 wherein said step of irradiating (step a)) includes reflecting radiation from a reflective surface placed behind said blood bag or said tubing.

5. The method of claim 2 wherein in said step of measuring (step b)), light leakages are compensated for by measuring dark current for both sample and reference measurements.

6. The method of claim 2 , wherein said one, or more than one analyte is selected from the group consisting of haemoglobin, bilirubin, biliverdin, equivalent intralipid, methylene blue and cross-linked haemoglobin.

7. The method of claim 1 , wherein said one, or more than one analyte is selected from the group consisting of haemoglobin, bilirubin, biliverdin, equivalent intralipid, methylene blue, and cross-linked haemoglobin.

8. A method for determining a concentration of one, or more than one of haemoglobin, bilirubin, biliverdin, equivalent intralipid, methylene blue and cross-linked haemoglobinin in a sample contained in a blood bag or in a tubing in fluid communication with said blood bag, using an instrument comprising one, or more than one calibration algorithm for each of said haemoglobin, bilirubin, biliverdin, equivalent intralipid, methylene blue and cross-linked haemoglobin, said method comprising:

a) irradiating said sample in said tubing or said blood bag using a radiation source of about 475 nm to about 2,700 nm;

b) measuring an absorbance of said sample, and

c) calculating a concentration for one, or more than one of said haemoglobin, bilirubin, biliverdin, equivalent intralipid, methylene blue and cross-linked haemoglobin by determining values of first derivatives of two, or more than two portions of a spectrum generated from said step of measuring (step b), and incorporating said first derivatives into said one, or more than one calibration algorithm to provide said concentration.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2012
From: NELLCOR PURITAN BENNETT LLC
To: COVIDIEN LP
Reel/Frame 029432/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2011
From: NIRESULTS, INC.
To: NELLCOR PURITAN BENNETT LLC
Reel/Frame 027064/0516 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2009
From: NIR DIAGNOSTICS INC.
To: NIRESULTS INC.
Reel/Frame 022473/0568 →
LICENSE TERMINATION Recorded Sep 12, 2008
From: NIR DIAGNOSTICS INC.
To: NIR DIAGNOSTICS INC.
Reel/Frame 021523/0155 →
EXCLUSIVE LICENSE Recorded Apr 9, 2007
From: NIR DIAGNOSTICS INC.
To: SHAKLEE CORPORATION
Reel/Frame 019140/0111 →
CHANGE OF NAME Recorded Jul 25, 2005
From: CME TELEMETRIX INC.
To: NIR DIAGNOSTICS INC.
Reel/Frame 016304/0186 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2002
From: SAMSOONDAR, JAMES; MACINTYRE, DUNCAN
To: CME TELEMETRIX, INC.
Reel/Frame 012881/0466 →
Continuity (5)
Continuation In Part 0936786300 · Sep 3, 1999
Continuation In Part 0936785900 · Sep 2, 1999
Provisional Application 6003855500 · Mar 3, 1997
Provisional Application 6003855400 · Mar 3, 1997
Related Publication 20020167667A1 · Nov 14, 2002